It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
[RAW_REF_TEXT] Correction [/RAW_REF_TEXT] [RAW_REF_TEXT] Open Access [/RAW_REF_TEXT] [RAW_REF_TEXT] Published:28 July 2022 [/RAW_REF_TEXT] Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy [RAW_REF_TEXT] Heng Li1 na1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Gan Yu1 na1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Runlin Shi1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Bin Lang3, [/RAW_REF_TEXT] [RAW_REF_TEXT] Xianguo Chen4, [/RAW_REF_TEXT] [RAW_REF_TEXT] Ding Xia1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Haibing Xiao1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Xiaolin Guo1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Wei Guan1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Zhangqun Ye1, [/RAW_REF_TEXT] [RAW_REF_TEXT] Wei Xiao 2 & [/RAW_REF_TEXT] [RAW_REF_TEXT] Hua Xu 1 [/RAW_REF_TEXT] Molecular Cancer volume 21, Article number: 155 (2022) Cite this article [RAW_REF_TEXT] 146 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] Correction: Mol Cancer 13, 8 (2014) https://doi.org/10.1186/1476-4598-13-8 Following publication of the original article [1], an error was identified in the images presented in Fig. 4, specifically: F Relative miR-34a expression in xenografts; G) Photographs of tumors excised 38 days after inoculation of stably transfected cells into nude mice; Mean xenograft tumor volume H) and weight I) in nude mice groups after indicated treatment (mean + SEM; n = 3; *p < 0.05) Full size image Figure 4B: incorrect images were originally used for Lenti-NC in 5637 cell line; the correct images are now used Furthermore, two of the primer sequences listed in the Table S1 (part of ‘Additional file 3: Correction Open Access Published:28 July 2022 [/RAW_REF_TEXT] Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy [RAW_REF_TEXT] Heng Li1 na1, Gan Yu1 na1, Runlin Shi1, Bin Lang3, Xianguo Chen4, Ding Xia1, Haibing Xiao1, Xiaolin Guo1, Wei Guan1, Zhangqun Ye1, Wei Xiao 2 & Hua Xu 1 [/RAW_REF_TEXT] Molecular Cancer volume 21, Article number: 155 (2022) Cite this article [RAW_REF_TEXT] 146 Accesses Metrics details
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer